The Hindu Businessline

DCGI flags regulatory risks as Pharma industry races to embrace AI at IIMA healthcare summit

The DGCI said regulators approve a product based on defined characteristics of quality, safety and performance and expect those characteristics to remain consistent through the products lifecycle